Cordio Medical

📍 Or Yehuda, Israel🗓 Founded 2013👥 34 employees💰 Last funded Jun 2025
Cordio Medical develops and provides groundbreaking solutions for monitoring health conditions through a patient’s voice. A patient’s free speech into a smartphone app backed by sophisticated and proprietary algorithms, allows near real-time monitoring and early detection of condition deterioration. Cordio Meds technologies are based on true speech signal processing technology, unique to each patient, augmented with machine learning capabilities. The system is patient-tailored, and is constantly learning the patient’s voice and providing personalized, seamless and effortless monitoring. Cordio’s goal is to identify and mitigate condition worsening by helping physicians prevent patient deterioration and hospitalization while keeping the patient involved and informed.
3
Total investors
0
Early stage
0
Mid stage
1
Late stage
2013
Founded
Investor geography2 countries
Israel
2
France
1
Investor activity2021–2025 · investors recorded per year
202112024120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Cordio Medical?
Cordio Medical has 3 investors on record on gritt.io and 1 late-stage investors.
When did Cordio Medical last raise funding?
The most recent investment in Cordio Medical recorded on gritt.io was in June 2025.
When was Cordio Medical founded?
Cordio Medical was founded in 2013.
What industry is Cordio Medical in?
Cordio Medical operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Cordio Medical based?
Cordio Medical is headquartered in Or Yehuda, Israel.